Viking Therapeutics Inc (VKTX)
75.75
-0.68
(-0.89%)
USD |
NASDAQ |
May 02, 16:00
75.75
0.00 (0.00%)
After-Hours: 16:12
Viking Therapeutics Cash from Investing (Quarterly): -459.79M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -459.79M |
December 31, 2023 | 35.73M |
September 30, 2023 | -12.53M |
June 30, 2023 | -204.48M |
March 31, 2023 | 2.198M |
December 31, 2022 | 7.26M |
September 30, 2022 | 26.89M |
June 30, 2022 | 18.98M |
March 31, 2022 | 1.619M |
December 31, 2021 | 27.41M |
September 30, 2021 | 13.62M |
June 30, 2021 | 3.56M |
March 31, 2021 | -6.627M |
December 31, 2020 | 30.27M |
September 30, 2020 | -9.634M |
June 30, 2020 | 9.78M |
March 31, 2020 | 11.15M |
December 31, 2019 | -11.06M |
September 30, 2019 | 15.15M |
June 30, 2019 | 10.98M |
Date | Value |
---|---|
March 31, 2019 | -7.609M |
December 31, 2018 | -142.39M |
September 30, 2018 | -27.09M |
June 30, 2018 | -66.62M |
March 31, 2018 | -29.63M |
December 31, 2017 | -4.396M |
September 30, 2017 | 1.392M |
June 30, 2017 | -0.765M |
March 31, 2017 | 2.039M |
December 31, 2016 | 1.447M |
September 30, 2016 | 0.441M |
June 30, 2016 | -4.831M |
March 31, 2016 | 5.973M |
December 31, 2015 | 1.956M |
September 30, 2015 | -3.252M |
June 30, 2015 | -12.17M |
March 31, 2015 | 0.00 |
December 31, 2014 | |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-459.79M
Minimum
Mar 2024
35.73M
Maximum
Dec 2023
-24.48M
Average
8.52M
Median
Cash from Investing (Quarterly) Benchmarks
Eli Lilly and Co | -1.178B |
Pfizer Inc | -11.00B |
Madrigal Pharmaceuticals Inc | -362.12M |
Akero Therapeutics Inc | 12.79M |
Terns Pharmaceuticals Inc | 47.23M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -6.134M |
Cash from Financing (Quarterly) | 606.04M |
Free Cash Flow | -54.87M |
Free Cash Flow Per Share (Quarterly) | -0.0593 |
Free Cash Flow Yield | -0.72% |